Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Equipe Genetique des Anomalies du Developpement, |
RCV001526652 | SCV001737083 | likely pathogenic | Intellectual disability | criteria provided, single submitter | clinical testing | ||
3billion | RCV005253849 | SCV005904406 | pathogenic | Cardiac anomalies - developmental delay - facial dysmorphism syndrome | 2023-10-23 | criteria provided, single submitter | clinical testing | The variant is not observed in the gnomAD v2.1.1 dataset. Predicted Consequence/Location: Stop-gained (nonsense): predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant. The variant has been previously reported as de novo in a similarly affected individual (PMID: 36368352). The variant has been reported to be associated with MED13L-related disorder (ClinVar ID: VCV001172667 /PMID: 36368352). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. |